Anaphylaxis

Epinephrine autoinjector administration competence varied among caregivers, indicating a need for better education, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Symptomology varies among adults with anaphylaxis depending on the trigger, according to a study published in International Archives of Allergy and Immunology.

The year 2024 was important for skin disorders with many innovations and breakthroughs.

Although this year brought many advances in the treatment of food allergy, the FDA’s approval of omalizumab dominated our most popular coverage.

This year brought breakthroughs and important advances in asthma and allergy. Healio’s most popular stories in 2024 covered the long-anticipated approval of neffy epinephrine nasal spray and an update to anaphylaxis practice parameters.

Travel can be stressful enough — especially around the holidays. For families with food allergy, however, the challenges are even harder.

A New York State Assemblymember celebrated the signing of two of her new bills into law that aim to expand epinephrine autoinjector accessibility across the state.

A study involving an oral allergen challenge revealed promising results for a sublingual epinephrine strip, a delivery method that is being evaluated as an alternative to epinephrine autoinjectors.

Healio has compiled November’s most read news in asthma and allergy.

BOSTON — Patients using lipid-lowering medications experienced increased anaphylaxis severity, according to an abstract presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.